TY - JOUR
T1 - The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions
T2 - Checklist and explanations
AU - Hutton, Bria
AU - Salanti, Georgi
AU - Caldwell, Deborah M.
AU - Chaimani, Ann
AU - Schmid, Christopher H.
AU - Cameron, Chri
AU - Ioannidis, John P.A.
AU - Straus, Sharo
AU - Thorlund, Kristia
AU - Jansen, Jeroen P.
AU - Mulrow, Cynthi
AU - Catala-Lopez, Ferra
AU - Gotzsche, Peter C.
AU - Dickersin, Ka
AU - Boutron, Isabell
AU - Altman, Douglas G.
AU - Moher, Davi
PY - 2015/6/2
Y1 - 2015/6/2
N2 - The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Metaanalyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-To-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
AB - The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Metaanalyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-To-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
UR - http://www.scopus.com/inward/record.url?scp=84932084410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84932084410&partnerID=8YFLogxK
U2 - 10.7326/M14-2385
DO - 10.7326/M14-2385
M3 - Article
C2 - 26030634
AN - SCOPUS:84932084410
SN - 0003-4819
VL - 162
SP - 777
EP - 784
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 11
ER -